Aminopyridazines as acetylcholinesterase inhibitors.
Article Details
- CitationCopy to clipboard
Contreras JM, Rival YM, Chayer S, Bourguignon JJ, Wermuth CG
Aminopyridazines as acetylcholinesterase inhibitors.
J Med Chem. 1999 Feb 25;42(4):730-41.
- PubMed ID
- 10052979 [ View in PubMed]
- Abstract
Following the discovery of the weak, competitive and reversible acetylcholinesterase (AChE)-inhibiting activity of minaprine (3c) (IC50 = 85 microM on homogenized rat striatum AChE), a series of 3-amino-6-phenylpyridazines was synthesized and tested for inhibition of AChE. A classical structure-activity relationship exploration suggested that, in comparison to minaprine, the critical elements for high AChE inhibition are as follows: (i) presence of a central pyridazine ring, (ii) necessity of a lipophilic cationic head, (iii) change from a 2- to a 4-5-carbon units distance between the pyridazine ring and the cationic head. Among all the derivatives investigated, 3-[2-(1-benzylpiperidin-4-yl)ethylamino]-6-phenylpyridazine (3y), which shows an IC50 of 0.12 microM on purified AChE (electric eel), was found to be one of the most potent anti-AChE inhibitors, representing a 5000-fold increase in potency compared to minaprine.1
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Minaprine Acetylcholinesterase Protein Humans YesInhibitorDetails - Binding Properties
Drug Target Property Measurement pH Temperature (°C) Donepezil Acetylcholinesterase IC 50 (nM) 16 N/A N/A Details Tacrine Acetylcholinesterase IC 50 (nM) 95 N/A N/A Details